SBIR/STTR Research Award

NOVEL APPROACH TO TIPS: STENT POLYMER PAVING COMPOSITES

Award identifier 2d20939d730dfff69274aeaadc7a9b2e349fc2e81b54ff0f2896a893a85ef9f8Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$92,775

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BERKLEY APPLIED SCIENCE & ENGR, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (Verbatim From Applicant's Abstract): In the management of cirrhotic patients with variceal bleeding, transjugular intra-hepatic portosystemic shunt (TIPS) plays an important role in decompressing the portal system and preventing the danger of frequent rebleeding. The advance of this less invasive, non-surgical approach of portal decompression was made possible through the clinical introduction of vascular stents. At first, balloon expandable stents, such as Palmaz stents or Tantalum Strecker stents were employed in TIPS procedure, however, in time, many switched to self-expanding stents such as Wallstent, Nitinol Stecker stents, Memotherm stents, or GianturcolRosch stents, which became more popular due to their easier deployment and variety of size available. However, there are intrinsic differences among all self-expanding stents regarding elasticity, length, diameter, longitudinal flexibility hoop strength, mesh profile, and delivery system, which influence their performance. Despite the clinical success of TIPS to date, several major challenges remain. Early malfunction of TIPS may occur due to tract closure resulting from bioleakage intralumina! thrombosis, incomplete stent expansion, or stent migration. More commonly, TIPS patency is compromised progressively in the months following placement due to tissue in-growth. These and other limitations of current TIPS practice must be resolved to ensure durable patency and efficacy rates for TIPS. It is the specific objective of this Phase I project to resolve some of these limitations through introduction of a composite nitinol stent combined with in adherent polymeric endoluminal layer. Berkeley Applied Science & Engineering, Inc. (BASE) has developed a unique expertise in using nitinol for various industrial and medical applications. The co-investigator, Dr. Slepian, was the original inventor and developer of polymeric endoluminal paving. During Phase l.a combination of strengths will be utilized, including mathematical simulation of BASE and the polymeric expertise of the Slepian lab. Prototype stent samples will be fabricated and a limited animal study will be done to demonstrate how present limitations of TIPS procedure can be improved. PROPOSED COMMERCIAL APPLICATION: Not Available

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.